HORMONAL PROFILE AND CHARACTERISTICS OF POLYCHISTIC OVARIUM SYNDROME (SOPK) IN MADURESE TRIBE, INDONESIA

zakkiyatus zainiyah

Abstract


Syndrome polycystic ovaries (PCOS), the most common endocrine disorders in women of reproductive age, characterized by menstrual disorders (amenorrhea/oligomenorrhea), hirsutism, the appearance of acne, alopecia and the results of biochemical tests that show increased androgens (testosterone). Increased serum LH and FSH serve as diagnostic tests for PCOS over the years, but from several research results obtained inconsistent results that need further research. The purpose of this study is to analyze the hormonal profile and characteristics of Polycystic Ovary Syndrome (PCOS) in Madura. study Case-control conducted in March-August 2019 in the Madura tribe, 32 subjects with PCOS and 32 healthy women. Hormonal examination using a serum and followed by ELISA kit. levels FSH Averagewere 8.74 and SHBGs were 10.02 lower in SOPK patients and LH levels were higher in SOPK patients.ratio LH / FSH 0.76. The results of the Madurese study showed that levels were FSH, LH, Weight and significantly related to PCOS (<0.05), SHBG and BMI levels were not related to PCOS (> 0.05).

References


El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly Cystic Ovarian Syndrome: An updated overview. Front Physiol 2016. 7 (APR): 1–15. 2016

Manlove HA. No Title 2011; (May). 2011

Ding T, Baio G, Hardiman PJ, Petersen I, Sammon C. Diagnosis and management of polycystic ovary syndrome in the UK): a retrospective cohort study 2004. 5–8. 2004

Thomson RL, Buckley JD, Brinkworth GD. Perceived exercise barriers are reduced and benefits are improved with lifestyle modification in overweight and obese women with polycystic ovary syndrome: a randomized controlled trial. BMC Womens Health 2016. Vol 16. No 14. 2016

Musmar S, Afaneh A, Mo'alla H. Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An -Facial national university-Palestine. Reprod Biol Endocrinol 2013. Vol 11. No 1: 47-52. 2013

Gourgari E, Spanakis E, US Dobs. Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome. Int J Womens Health 2016. Vol 8. No 2: 381-7. 2016

BCJM Fauser. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Sterile Fertil 2004. Vol 81. No 1: 19-25. 2004

Ramezanali F, Khalili G, Arabipoor A, Bagheri Lankarani N, Moini A. Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia. Int J Fertil Sterile 2016. Vol 10. No 1: 36–41. 2016

Benson RC. Clinical Gynecologic Endocrinology and Infertility. West J Med 1974. Vol 121. No2: 52–64. 1974

Mustari DA, Rostini T, Indrati AR, Bayuaji H RS. Correlation of Amtral Follicular Amounts with Serum 25 (OH) D Levels in Patients with Polycystic Ovary Syndrome Correlation between Antral Follicles Count and Serum 25 (OH) D Levels in Polycystic Ovary Syndrome Patients 2018. Vol 50. No 4: 4–9. 2018

Fazleen NE, Whittaker M, Mamun A. Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: A systematic review and meta-analysis. Diabetes Metab Syndr Clin Res Rev 2018. Vol 2. No 4. 2018

Pinola P, Puukka K, Piltonen TT, Puurunen J, Vanky E, Sundström-Poromaa I, et al. Normally and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life. Sterile Fertil 2017. Vol 107. No 3: 788-795.2017

Maredia H, Hawley NL, Lambert-Messerlian G, Fidow U, Reupena MS, Naseri T, et al. Reproductive health, obesity, and cardiometabolic risk factors among Samoan women. Am J Hum Biol 2018. Vol 3. No 6: 45-53. 2018

Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. Comparison of clinical and hormonal characteristics among the four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Arch Gynecol Obstet 2016. Vol 293. No 2: 447-56. 2016

Bailey AP, Hawkins LK, Missmer SA, Correia KF, Yanushpolsky EH. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome. Am J Obstet Gynecol 2014. Vol 211. No 2:163-169.2014

Robert J Norman, Didier Dewailly, Richard S Legro TEA, Polycystic. Polycystic Ovary Syndrome. Lancet 2007. Vol 370. No3: 685–97.2007

Diamanti-Kandarakis E. Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes 2007. Vol 31. No 2:8–13.2007

Huang J, Ni R, Chen X, Huang L, Mo Y, Yang D. Metabolic abnormalities in adolescents with polycystic ovary syndrome in South China. Reprod Biol Endocrinol 2010. Vol 8. No 1: 142-149.2010

Bassiouny YES, Rabie WA, Hassan AA, Darwish RK. Association of the luteinizing hormone / choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome 2014. Vol 3590. No 6: 428-30.2014

Mukherjee S, Shaikh N, Khavale S, Shinde G, Meherji P, Shah N, et al. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome. Eur J Endocrinol 2009. Vol 160. No 5: 855–62. 2009

Martinez-Bermejo M .; Escobar-Morreale, HFE LR. Obesity and the polycystic ovary syndrome. Minerva Endocrinol. 2007; 32 (3): 129–40.

Zhang J, Hu J, Zhang C, Jiao Y, Kong X, Wang W. Analyzed of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease. Exp Ther Med 2018. Vol 15. No 5: 4259–64. 2018

Ates S, Aydın S, Ozcan P, Soyman Z, Gokmen Karasu AF, Sevket O. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome. J Obstet Gynaecol (Lahore) 2017. Vol 1 (10): 1–5.2017

Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 2009. Vol 15. No 4: 477-88. 2009

Saghafi-Asl M, Pirouzpanah S, Ebrahimi-Mameghani M, Asghari-Jafarabadi M, Aliashrafi S, Sadein B. Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome. Heal Promot Perspect 2013. Vol 3. No 2:206–16.2013

Leo V De, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 2016. Vol 3. No 4: 1–17. 2016

Parlak, M., Parlak, AE, & Toslak, IE. Etiologic Factors and Clinical Characteristics of Turkish Adolescent Girls Diagnosed with Hirsutism Journal of Clinical and Analytical Medicine 2016. Vol 7. No 2:205-209. 2016

Malini NA, Roy George K. Evaluation of different ranges of LH: FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study. Endocrinol Comp gene 2018. Vol 260. No 2: 51-7. 2018

Malini NA, Roy George K. Evaluation of different ranges of LH: FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study. Gene Comp Endocrinol 2018. Vol 260. No 3:51-7. 2018

Turhan NÖ, Toppare MF, Seçkin NC, Dilmen G. The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea . Gynecol Obstet Invest 1999. Vol 48. No 3: 183–6. 1999

Behbahani BM, Akbaezadeh M. Central Obesity and BMI Associated with Different Phenotypes of Polycystic Ovary Syndrome in Adolescent. Int J of Pub Health Scie 2017. Vol 6. No 4: 356-359. 2017




DOI: http://doi.org/10.11591/ijphs.v9i4.20408
Total views : 6 times

Refbacks

  • There are currently no refbacks.


International Journal of Public Health Science (IJPHS)
p-ISSN: 2252-8806, e-ISSN: 2620-4126

View IJPHS Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.